Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prolonged cholestasis with ductopenia after administration of amoxicillin/clavulanic acid.

Literature DB >> 10548348

Prolonged cholestasis with ductopenia after administration of amoxicillin/clavulanic acid.

J P Richardet¹, A Mallat, E S Zafrani, M Blazquez, J C Bognel, B Campillo.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 1999 PMID： 10548348 DOI： 10.1023/a:1026610015899

Source DB: PubMed Journal: Dig Dis Sci ISSN： 0163-2116 Impact factor: 3.199

× No keyword cloud information.

23 in total

1. Risk of acute liver injury associated with the combination of amoxicillin and clavulanic acid.

Authors: L A García Rodríguez; B H Stricker; H J Zimmerman
Journal: Arch Intern Med Date: 1996-06-24

2. Granulomatous hepatitis due to combination of amoxicillin and clavulanic acid.

Authors: C Silvain; E Fort; P Levillain; J Labat-Labourdette; M Beauchant
Journal: Dig Dis Sci Date: 1992-01 Impact factor: 3.199

3. [Acute hepatitis caused by Solupred in a patient with Crohn disease].

Authors: R Gerolami; P Mambrini; M Barthet; M J Jean-Pastor; J Salducci; J C Grimaud
Journal: Gastroenterol Clin Biol Date: 1997

4. Trimethoprim-sulfamethoxazole-induced vanishing bile duct syndrome.

Authors: F Yao; C A Behling; S Saab; S Li; M Hart; K D Lyche
Journal: Am J Gastroenterol Date: 1997-01 Impact factor: 10.864

5. Vanishing bile duct syndrome temporally associated with ibuprofen use.

Authors: I Alam; L D Ferrell; N M Bass
Journal: Am J Gastroenterol Date: 1996-08 Impact factor: 10.864

6. Liver injury related to amoxycillin-clavulanic acid: interlobular bile-duct lesions and extrahepatic manifestations.

Authors: M L Hautekeete; R Brenard; Y Horsmans; J Henrion; L Verbist; G Derue; P Druez; M Omar; M Kockx; H Hubens
Journal: J Hepatol Date: 1995-01 Impact factor: 25.083

Review 7. The syndrome of disappearing intrahepatic bile ducts.

Authors: S Sherlock
Journal: Lancet Date: 1987-08-29 Impact factor: 79.321

8. Amoxicillin-clavulanate potassium-associated cholestasis.

Authors: K R Reddy; P Brillant; E R Schiff
Journal: Gastroenterology Date: 1989-04 Impact factor: 22.682

9. Drug-induced prolonged cholestasis in adults: a histological semiquantitative study demonstrating progressive ductopenia.

Authors: C Degott; G Feldmann; D Larrey; A M Durand-Schneider; D Grange; J P Machayekhi; A Moreau; F Potet; J P Benhamou
Journal: Hepatology Date: 1992-02 Impact factor: 17.425

Prolonged cholestasis with ductopenia after administration of amoxicillin/clavulanic acid.

1. Risk of acute liver injury associated with the combination of amoxicillin and clavulanic acid.

2. Granulomatous hepatitis due to combination of amoxicillin and clavulanic acid.

3. [Acute hepatitis caused by Solupred in a patient with Crohn disease].

4. Trimethoprim-sulfamethoxazole-induced vanishing bile duct syndrome.

5. Vanishing bile duct syndrome temporally associated with ibuprofen use.

6. Liver injury related to amoxycillin-clavulanic acid: interlobular bile-duct lesions and extrahepatic manifestations.

Review 7. The syndrome of disappearing intrahepatic bile ducts.

8. Amoxicillin-clavulanate potassium-associated cholestasis.

9. Drug-induced prolonged cholestasis in adults: a histological semiquantitative study demonstrating progressive ductopenia.

10. Sialadenitis and systemic reaction associated with phenylbutazone.

1. Drug-Induced Liver Disease.

2. Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements.

3. Mycophenolate mofetil for drug-induced vanishing bile duct syndrome.

Review 4. Drug-Induced Liver Injury: Pattern Recognition and Future Directions.